Cited by 166Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyUbiquitin and proteasome pathways

The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.

Degradation of tau protein by autophagy and proteasomal pathways

Wang, Yipeng, Mandelkow, Eckhard·2012·Biochemical Society Transactions

DOI 10.1042/bst20120071

Open this paper in CoChat — free account

Abstract

Tau aggregates are present in several neurodegenerative diseases and correlate with the severity of memory deficit in AD (Alzheimer's disease). However, the triggers of tau aggregation and tau-induced neurodegeneration are still elusive. The impairment of protein-degradation systems might play a role in such processes, as these pathways normally keep tau levels at a low level which may prevent aggregation. Some proteases can process tau and thus contribute to tau aggregation by generating amyloidogenic fragments, but the complete clearance of tau mainly relies on the UPS (ubiquitin–proteasome system) and the ALS (autophagy–lysosome system). In the present paper, we focus on the regulation of the degradation of tau by the UPS and ALS and its relation to tau aggregation. We anticipate that stimulation of these two protein-degradation systems might be a potential therapeutic strategy for AD and other tauopathies.

Integrity signals

Registry

Crossref · 10.1042/bst20120071

Cites

102 of 102 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Molecular chaperones in protein folding and proteostasis
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011) · Nature · doi:10.1038/nature10317 · Cited by 3,381
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders
Ballatore, C., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2194 · Cited by 2,174
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Recognition of the polyubiquitin proteolytic signal
Thrower, J. S., Hoffman, L. M., Rechsteiner, M., & Pickart, C. M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,769
The roles of intracellular protein-degradation pathways in neurodegeneration
Rubinsztein, D. C. (2006) · Nature · doi:10.1038/nature05291 · Cited by 1,625
Autophagy Induction and Autophagosome Clearance in Neurons: Relationship to Autophagic Pathology in Alzheimer's Disease
Boland, B., Kumar, A., Lee, S., Platt, F. M., Wegiel, J., Yu, W. H., & Nixon, R. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-08.2008 · Cited by 1,119
Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967

Flagged first, then by citations

Show all 102 references

Sorted by citations

Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Self-citation
Tau-targeting therapies for Alzheimer disease
Congdon, E. E., & Sigurdsson, E. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0013-z · Cited by 1,113
Roles of tau protein in health and disease
Guo, T., Noble, W., & Hanger, D. P. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1707-9 · Cited by 1,003
Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516
Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
Pajares, M., Jiménez-Moreno, N., García-Yagüe, Á. J., Escoll, M., de Ceballos, M. L., Van Leuven, F., Rábano, A., Yamamoto, M., Rojo, A. I., & Cuadrado, A. (2016) · Autophagy · doi:10.1080/15548627.2016.1208889 · Cited by 392
Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
Alquezar, C., Arya, S., & Kao, A. W. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.595532 · Cited by 367
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome
Salminen, A., Kaarniranta, K., Kauppinen, A., Ojala, J. O., Haapasalo, A., Soininen, H. S., & Hiltunen, M. O. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.06.002 · Cited by 371
Role of lysosomes in physiological activities, diseases, and therapy
Zhang, Z., Yue, P., Lu, T., Wang, Y., Wei, Y., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01087-1 · Cited by 375
Self-citation
Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
Silva, M. C., Ferguson, F. M., Cai, Q., Donovan, K. A., Nandi, G., Patnaik, D., Zhang, T., Huang, H.-T., Lucente, D. E., Dickerson, B. C., et al. (2019) · eLife · doi:10.7554/elife.45457 · Cited by 283
Phospholipase D Signaling Pathways and Phosphatidic Acid as Therapeutic Targets in Cancer
Bruntz, R. C., Lindsley, C. W., & Brown, H. A. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009217 · Cited by 286
Lost after translation: missorting of Tau protein and consequences for Alzheimer disease
Zempel, H., & Mandelkow�, E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.004 · Cited by 284
Self-citation
Autophagic and lysosomal defects in human tauopathies: analysis of post-mortem brain from patients with familial Alzheimer disease, corticobasal degeneration and progressive supranuclear palsy
Piras, A., Collin, L., Grüninger, F., Graff, C., & Rönnbäck, A. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0292-9 · Cited by 271
Diabetes and Alzheimer’s disease crosstalk
Baglietto‐Vargas, D., Shi, J. J., Yaeger, D. M., Ager, R. R., & LaFerla, F. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.005 · Cited by 263
Specific Knockdown of Endogenous Tau Protein by Peptide-Directed Ubiquitin-Proteasome Degradation
Chu, T.-T., Gao, N., Li, Q.-Q., Chen, P.-G., Yang, X.-F., Chen, Y.-X., Zhao, Y.-F., & Li, Y.-M. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2016.02.016 · Cited by 247
Four-repeat tauopathies
Rösler, T. W., Marvian, A. T., Brendel, M., Nykänen, N.-P., Höllerhage, M., Schwarz, S. C., Hopfner, F., Koeglsperger, T., Respondek, G., Schweyer, K., et al. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101644 · Cited by 231
Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease
Bhatia, V., & Sharma, S. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117253 · Cited by 228
Clearance of Amyloid Beta and Tau in Alzheimer’s Disease: from Mechanisms to Therapy
Xin, S.-H., Tan, L., Cao, X., Yu, J.-T., & Tan, L. (2018) · Neurotoxicity Research · doi:10.1007/s12640-018-9895-1 · Cited by 222
The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer’s Disease
Liu, Z., Li, T., Li, P., Wei, N., Zhao, Z., Liang, H., Ji, X., Chen, W., Xue, M., & Wei, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/352723 · Cited by 217
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
Zhang, W., Xu, C., Sun, J., Shen, H., Wang, J., & Yang, C. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.008 · Cited by 221
It’s all about tau
Tapia‐Rojas, C., Cabezas-Opazo, F., Deaton, C. A., Vergara, E. H., Johnson, G. V. W., & Quintanilla, R. A. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.12.005 · Cited by 207
The Autophagy Lysosomal Pathway and Neurodegeneration
Finkbeiner, S. (2020) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033993 · Cited by 196
Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies
Limorenko, G., & Lashuel, H. A. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00127b · Cited by 168
Targeting Autophagy for the Treatment of Alzheimer’s Disease: Challenges and Opportunities
Liu, J., & Li, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00203 · Cited by 162
Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer’s disease
Chiasseu, M., Alarcón-Martínez, L., Belforte, N., Quintero, H., Dotigny, F., Destroismaisons, L., Velde, C. V., Panayi, F., Louis, C., & Polo, A. D. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0199-3 · Cited by 158
Prolonged tau clearance and stress vulnerability rescue by pharmacological activation of autophagy in tauopathy neurons
Silva, M. C., Nandi, G. A., Tentarelli, S., Gurrell, I. K., Jamier, T., Lucente, D., Dickerson, B. C., Brown, D. G., Brandon, N. J., & Haggarty, S. J. (2020) · Nature Communications · doi:10.1038/s41467-020-16984-1 · Cited by 157
SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy
Min, S., Sohn, P., Li, Y., Devidze, N., Johnson, J. R., Krogan, N. J., Masliah, E., Mok, S., Gestwicki, J. E., & Gan, L. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2369-17.2018 · Cited by 151
Autophagic dysfunction in Alzheimer’s disease: Cellular and molecular mechanistic approaches to halt Alzheimer’s pathogenesis
Uddin, M. S., Mamun, A. A., Labu, Z. K., Hidalgo‐Lanussa, O., Barreto, G. E., & Ashraf, G. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27588 · Cited by 141
New Insights Into Drug Discovery Targeting Tau Protein
Soeda, Y., & Takashima, A. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.590896 · Cited by 136
Acetylation: a new key to unlock tau’s role in neurodegeneration
Cook, C. N., Stankowski, J. N., Carlomagno, Y., Stetler, C. T., & Petrucelli, L. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt259 · Cited by 140
Development of disease-modifying drugs for frontotemporal dementia spectrum disorders
Panza, F., Lozupone, M., Seripa, D., Daniele, A., Watling, M., Giannelli, G., & Imbimbo, B. P. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0330-x · Cited by 122
The Role of Tau Oligomers in the Onset of Alzheimer's Disease Neuropathology
Cárdenas-Aguayo, M. D. C., Gómez-Virgilio, L., DeRosa, S., & Meraz-Ríos, M. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500148z · Cited by 120
New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
Medina, M., & Ávila, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.013 · Cited by 123
The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease
Gadhave, K., Bolshette, N. B., Ahire, A., Pardeshi, R., Thakur, K. K., Trandafir, C.-M., Istrate, A., Ahmed, S., Lahkar, M., Muresanu, D. F., et al. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12817 · Cited by 122
Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease
Bonfili, L., Cecarini, V., Gogoi, O., Gong, C., Cuccioloni, M., Angeletti, M., Rossi, G., & Eleuteri, A. M. (2020) · FEBS Journal · doi:10.1111/febs.15571 · Cited by 123
Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
Jiang, S., & Bhaskar, K. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.586731 · Cited by 119
Tau Protein Squired by Molecular Chaperones During Alzheimer’s Disease
Gorantla, N. V., & Chinnathambi, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1174-3 · Cited by 113
Glucose metabolism and AD: evidence for a potential diabetes type 3
González, A., Calfío, C., Churruca, M., & Maccioni, R. B. (2022) · Alzheimer's Research & Therapy · doi:10.1186/s13195-022-00996-8 · Cited by 112
Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats
Song, X., Hu, J.-F., Chu, S., Zhang, Z., Xu, S., Yuan, Y., Han, N., Liu, Y., Niu, F., He, X., et al. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.03.051 · Cited by 107
Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma
Chiasseu, M., Vargas, J. L. C., Destroismaisons, L., Velde, C. V., Leclerc, N. M., & Polo, A. D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3986-15.2016 · Cited by 105
Human iPSC-derived neuronal model of Tau-A152T frontotemporal dementia reveals tau-mediated mechanisms of neuronal vulnerability
Silva, M. C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M. H. U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.001 · Cited by 103
The role of ubiquitin proteasomal system and autophagy-lysosome pathway in Alzheimer’s disease
Zhang, Y., Chen, X., Zhao, Y., Ponnusamy, M., & Liu, Y. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0013 · Cited by 99
Stages and Conformations of the Tau Repeat Domain during Aggregation and Its Effect on Neuronal Toxicity
Kumar, S., Tepper, K., Kaniyappan, S., Biernat, J., Wegmann, S., Mandelkow, E., Müller, D. J., & Mandelkow�, E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.554725 · Cited by 88
Self-citation
Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
Silva, M. C., & Haggarty, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21238948 · Cited by 89
Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration
Gentry, E. G., Henderson, B. W., Arrant, A. E., Gearing, M., Feng, Y., Riddle, N. C., & Herskowitz, J. H. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2336-15.2016 · Cited by 90
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation
Komaroff, A. L., Pellett, P. E., & Jacobson, S. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00143-20 · Cited by 77
A critical appraisal of tau‐targeting therapies for primary and secondary tauopathies
Imbimbo, B. P., Ippati, S., Watling, M., & Balducci, C. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12453 · Cited by 75
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Ye, H., Han, Y., Li, P., Su, Z., & Huang, Y. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02002-0 · Cited by 76
A Decade of Boon or Burden: What Has the CHIP Ever Done for Cellular Protein Quality Control Mechanism Implicated in Neurodegeneration and Aging?
Joshi, V., Amanullah, A., Upadhyay, A., Mishra, R., Kumar, A., & Mishra, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00093 · Cited by 77
Impaired protein degradation in FTLD and related disorders
Götzl, J. K., Lang, C. M., Haass, C., & Capell, A. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.008 · Cited by 75
The mammalian target of rapamycin at the crossroad between cognitive aging and Alzheimer’s disease
Talboom, J. S., Velázquez, R., & Oddo, S. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.8 · Cited by 67
Filamentous Aggregates Are Fragmented by the Proteasome Holoenzyme
Cliffe, R., Sang, J. C., Kundel, F., Finley, D. J., Klenerman, D., & Ye, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.096 · Cited by 62
Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer’s disease neuropathology
Hossain, M. F., Wang, N., Chen, R., Li, S., Roy, J., Uddin, M. G., Li, Z., Lim, L. W., & Song, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101304 · Cited by 62
Exosomes, autophagy and ER stress pathways in human diseases: Cross-regulation and therapeutic approaches
Jahangiri, B., Saei, A. K., Obi, P. O., Asghari, N., Lorzadeh, S., Hekmatirad, S., Rahmati, M., Velayatipour, F., Asghari, M. H., Saleem, A., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166484 · Cited by 62
Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum
Shahheydari, H., Ragagnin, A., Walker, A. K., Toth, R. P., Vidal, M., Jagaraj, C. J., Perri, E. R., Konopka, A., Sultana, J. M., & Atkin, J. D. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00119 · Cited by 61
Tau-Targeted Multifunctional Nanoinhibitor for Alzheimer’s Disease
Zhu, L., Xu, L., Wu, X., Dèng, F., Ma, R., Liu, Y., Huang, F., & Shi, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00257 · Cited by 59
Chaperone-assisted E3 ligase CHIP: A double agent in cancer
Kumar, S., Basu, M., & Ghosh, M. K. (2021) · Genes & Diseases · doi:10.1016/j.gendis.2021.08.003 · Cited by 59
The potential roles of deubiquitinating enzymes in brain diseases
Lim, K., Joo, J., & Baek, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101088 · Cited by 59
Chronic Administration of Dimebon Ameliorates Pathology in Tau P301S Transgenic Mice
Peters, O. M., Connor‐Robson, N., Sokolov, V. B., Aksinenko, A. Y., Kukharsky, M. S., Бачурин, С. О., Ninkina, N. N., & Buchman, V. L. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121732 · Cited by 54
Isoform-selective Genetic Inhibition of Constitutive Cytosolic Hsp70 Activity Promotes Client Tau Degradation Using an Altered Co-chaperone Complement
Fontaine, S. N., Rauch, J. N., Nordhues, B. A., Assimon, V. A., Stothert, A. R., Jinwal, U. K., Sabbagh, J. J., Chang, L., Stevens, S. M., Zuiderweg, E. R. P., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.637595 · Cited by 50
Tau-Directed Immunotherapy: A Promising Strategy for Treating Alzheimer’s Disease and Other Tauopathies
Schroeder, S. K., Joly‐Amado, A., Gordon, M. N., & Morgan, D. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9637-6 · Cited by 51
A Comprehensive Review of Essential Oils and Their Pharmacological Activities in Neurological Disorders: Exploring Neuroprotective Potential
Qneibi, M., Bdir, S., Maayeh, C., Bdair, M., Sandouka, D., Basit, D., & Hallak, M. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04032-5 · Cited by 55
Chaperones—A New Class of Potential Therapeutic Targets in Alzheimer’s Disease
Batko, J., Antosz, K., Miśków, W., Pszczołowska, M., Walczak, K., & Leszek, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063401 · Cited by 50
Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62
Jung, H.-J., Kim, Y.-J., Eggert, S., Chung, K. C., Choi, K. S., & Park, S. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.07.013 · Cited by 47
Microtubule affinity–regulating kinase 4 with an Alzheimer's disease-related mutation promotes tau accumulation and exacerbates neurodegeneration
Oba, T., Saito, T., Asada, A., Shimizu, S., Iijima, K., & Ando, K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014420 · Cited by 44
Nitazoxanide, an anti-parasitic drug, efficiently ameliorates learning and memory impairments in AD model mice
Fan, L., Qiu, X., Zhu, Z., Lv, J., Lu, J., Mao, F., Zhu, J., Wang, J., Guan, X., Chen, J., et al. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0220-1 · Cited by 46
Axonal dystrophy in the brain of mice with Sanfilippo syndrome
Beard, H., Hassiotis, S., Gai, W., Parkinson-Lawrence, E. J., Hopwood, J. J., & Hemsley, K. M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.06.010 · Cited by 43
LRRK2 Promotes Tau Accumulation, Aggregation and Release
Guerreiro, P. S., Gerhardt, E., da Fonseca, T. L., Bähr, M., Outeiro, T. F., & Eckermann, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9209-z · Cited by 46
Implication of type 4 NADPH oxidase (NOX4) in tauopathy
Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Senar, S., Sánchez‐Ramos, C., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.redox.2021.102210 · Cited by 44
Making the Brain Glow: In Vivo Bioluminescence Imaging to Study Neurodegeneration
Hochgräfe, K., & Mandelkow, E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8379-1 · Cited by 41
Self-citation
Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
Shin, S. J., Park, Y. H., Jeon, S. G., Kim, S., Nam, Y., Oh, S., Lee, Y. Y., & Moon, M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7829842 · Cited by 38
Mechanisms and therapeutic potential of interactions between human amyloids and viruses
Michiels, E., Rousseau, F., & Schymkowitz, J. W. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03711-8 · Cited by 37
Medial septum tau accumulation induces spatial memory deficit via disrupting medial septum–hippocampus cholinergic pathway
Wu, D., Gao, D., Yu, H.-T., Pi, G.-L., Xiong, R., Lei, H., Wang, X., Liu, E.-J., Ye, J.-W., Yu, H.-L., et al. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.428 · Cited by 30
Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer
Akoury, E., Mukrasch, M. D., Biernat, J., Tepper, K., Ozenne, V., Mandelkow�, E., Blackledge, M. J., & Zweckstetter, M. (2016) · Protein Science · doi:10.1002/pro.2911 · Cited by 32
Self-citation
Carboxy Terminus Heat Shock Protein 70 Interacting Protein Reduces Tau-Associated Degenerative Changes
Saidi, L.-J., Polydoro, M., Kay, K. R., Sanchez, L., Mandelkow, E., Hyman, B. T., & Spires‐Jones, T. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142094 · Cited by 34
Self-citation
Spermine increases acetylation of tubulins and facilitates autophagic degradation of prion aggregates
Phadwal, K., Kurian, D., Salamat, M. K. F., MacRae, V. E., Diack, A. B., & Manson, J. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-28296-y · Cited by 33
PEG-Ceramide Nanomicelles Induce Autophagy and Degrade Tau Proteins in N2a Cells
Gao, J., Chen, X., Ma, T., He, B., Li, P., Zhao, Y., Ma, Y., Zhuang, J., & Yin, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s258311 · Cited by 28
A Distinct Tau Code Controlled by HDAC6 is Linked to Tau Pathogenesis and the Neuronal Stress Response
Tseng, J., Ajit, A., Tabassum, Z., Patel, N., Tian, X., Chen, Y., Prevatte, A. W., Ling, K., Rigo, F., Meeker, R. B., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2021.109037 · Cited by 27
Tau mRNA 3′UTR-to-CDS ratio is increased in Alzheimer disease
García‐Escudero, V., Gargini, R., Martín-Maestro, P., García, E., García‐Escudero, R., & Ávila, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.007 · Cited by 25
Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system
Mielenz, D., & Gunn-Moore, F. (2016) · Biochemical Journal · doi:10.1042/bcj20160168 · Cited by 24
Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma
Hedna, R., Kovacic, H., Pagano, A., Peyrot, V., Robin, M., Devred, F., & Breuzard, G. (2022) · Cancers · doi:10.3390/cancers14215386 · Cited by 25
Defective proteostasis in induced pluripotent stem cell models of frontotemporal lobar degeneration
Mahali, S., Martinez, R., King, M., Verbeck, A., Harari, O., Benitez, B. A., Horie, K., Sato, C., Temple, S., & Karch, C. M. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02274-5 · Cited by 33
Could autophagy dysregulation link neurotropic viruses to Alzheimer’s disease?
Romeo, M. A., Faggioni, A., & Cirone, M. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253508 · Cited by 22
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice
Feng, T., Du, H., Yang, C., Wang, Y., & Hu, F. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02702-4 · Cited by 22
Self-citation
The Co-chaperone BAG2 Mediates Cold-Induced Accumulation of Phosphorylated Tau in SH-SY5Y Cells
de Paula, C. A. D., Santiago, F. E., Oliveira, A. S., Oliveira, F. A., Almeida, M. C., & Carrettiero, D. C. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0239-x · Cited by 21
A Central Role for Phosphorylated p38α in Linking Proteasome Inhibition-Induced Apoptosis and Autophagy
Guo, F., He, X., Li, S., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0260-1 · Cited by 21
Upregulation of ISG15 induced by MAPT/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease
Liu, Q. R., Wang, X., Fang, Z., Zhao, J.-N., RUI, X., Zhang, B., He, Y., Liu, R., Chen, J., Chai, G., et al. (2024) · Autophagy · doi:10.1080/15548627.2024.2431472 · Cited by 20
Mystery of methamphetamine-induced autophagosome accumulation in hippocampal neurons: loss of syntaxin 17 in defects of dynein–dynactin driving and autophagosome–late endosome/lysosome fusion
Xu, H., Zhu, Y., Chen, X., Yang, T., Wang, X., Xu, S., Xie, X., Hu, M., Jiang, L., Cheng, J., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03131-y · Cited by 20
New Insights into the Molecular Interplay between Human Herpesviruses and Alzheimer’s Disease—A Narrative Review
Athanasiou, E., Gargalionis, A. N., Anastassopoulou, C. G., Tsakris, A., & Boufidou, F. (2022) · Brain Sciences · doi:10.3390/brainsci12081010 · Cited by 20
Herpesviridae, Neurodegenerative Disorders and Autoimmune Diseases: What Is the Relationship between Them?
Francesco, M. A. D. (2024) · Viruses · doi:10.3390/v16010133 · Cited by 22
Decreased Proteasomal Function Induces Neuronal Loss and Memory Impairment
Tomaru, U., Ito, T., Ohmura, Y., Higashikawa, K., Miyajima, S., Tomatsu, R., Higashi, T., Ishizu, A., Kuge, Y., Yoshioka, M., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.10.004 · Cited by 20
AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy
Deng, Y., Wang, S., Wang, Q., Xu, Z., Peng, Q., Chen, S., Zhu, L., Zhang, Y., & Duan, R. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s392599 · Cited by 18
Cellular levels of growth factor receptor bound protein 2 (Grb2) and cytoskeleton stability are correlated in a neurodegenerative scenario
Majumder, P., Roy, K., Singh, B. K., Jana, N. R., & Mukhopadhyay, D. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027748 · Cited by 19
NPAS4 Facilitates the Autophagic Clearance of Endogenous Tau in Rat Cortical Neurons
Fan, W., Long, Y., Lai, Y., Wang, X., Chen, G., & Zhu, B. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0692-5 · Cited by 18
Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer’s disease
Seplovich, G., Bouchi, Y., Vaccari, J. P. D. R., Pareja, J. C. M., Reisner, A., Blackwell, L. S., Mechref, Y. S., Wang, K., Tyndall, J. A., Tharakan, B., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00107 · Cited by 21
Molecular Basis of Neuronal Autophagy in Ageing: Insights from Caenorhabditis elegans
Konstantinidis, G., & Tavernarakis, N. (2021) · Cells · doi:10.3390/cells10030694 · Cited by 19
Age-dependent changes in synaptic plasticity enhance tau oligomerization in the mouse hippocampus
Kimura, T., Suzuki, M., & Akagi, T. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0469-x · Cited by 17
Testing the link between isoaspartate and Alzheimer's disease etiology
Wang, J., Guo, C., Meng, Z., Zwan, M. D., Chen, X., Seelow, S., Lundström, S. L., Rodin, S., Teunissen, C. E., & Zubarev, R. A. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12735 · Cited by 16
Novel Cell Model for Tauopathy Induced by a Cell-Permeable Tau-Related Peptide
Veloria, J. R., Li, L., Breen, G. A. M., & Goux, W. J. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00275 · Cited by 16
Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species
Lee, J., Lee, B., Lee, H. G., Kim, E. J. E., Kim, S. S., Kwon, H. C., Lee, H., Lee, G., Hong, W., Ham, S., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2505217122 · Cited by 15
Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease
Thomas, S., Hoxha, K., Tran, A., & Prendergast, G. C. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29142 · Cited by 15

Authors: Wang, Y., & Mandelkow, E.
Affiliations: German Center for Neurodegenerative Diseases (DE)
German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany
Corresponding author: Wang, Yipeng
ORCID: Wang, Yipeng
Venue: Biochemical Society Transactions
Publisher: Portland Press Ltd.
Published: 2012-07-20
Volume: 40
Issue: 4
Pages: 644-652
ISSN: 0300-5127 (ISSN-L)
1470-8752
DOI: 10.1042/bst20120071
OpenAlex: W2149107089
Semantic Scholar: d284a357b1c845f43f0ed4c30e07818cb0344a3c
Cited by: 166
References: 102
Citations by year: 2026: 2 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 18 · 2021: 16 · 2020: 25 · 2019: 11 · 2018: 13 · 2017: 12 · 2016: 16 · 2015: 14 · 2014: 7 · 2013: 6 · 2012: 2
FWCI: 0.98
Type: journal article
Language: en
Open access: closed
Locations: Biochemical Society Transactions (publishedVersion)
PubMed (publishedVersion)
Max Planck Institute for Plasma Physics (submittedVersion)
DZNE Pub (submittedVersion)
MPG.PuRe (Max Planck Society) (submittedVersion)
Funders: Wellcome Trust
Bundesministerium für Bildung und Forschung
Tau Consortium
Medical Research Council (MC_G1000734)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords: tau protein, tau aggregation, protein degradation, ubiquitin-proteasome system, autophagy-lysosome system, Alzheimer's disease, tauopathy, neurodegeneration, proteolytic enzymes, therapeutic target
MeSH terms: Animals, Autophagy, Humans, Signal Transduction, tau Proteins, Proteasome Endopeptidase Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Degradation of tau protein by autophagy and proteasomal pathways

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks